Agency Information Collection Activities: Proposed Collection; Comments Requested, 33775 [E7-11783]
Download as PDF
Federal Register / Vol. 72, No. 117 / Tuesday, June 19, 2007 / Notices
desires to manufacture a quantity of
such class, or who desires to
manufacture using the List I chemicals
ephedrine, pseudoephedrine, or
phenylpropanolamine, must apply on
DEA Form 189 for a manufacturing
quota for such quantity of such class or
List I chemical.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: DEA estimates that each form
takes 0.5 hours (30 minutes) to
complete. In total, 37 firms submit 298
responses, with each response taking 0.5
hours (30 minutes) to complete. This
results in a total public burden of 149
hours annually.
(6) An estimate of the total public
burden (in hours) associated with the
collection: In total, 37 firms submit 298
responses, with each response taking 0.5
hours (30 minutes) to complete. This
results in a total public burden of 149
hours annually.
If additional information is required
contact: Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: June 12, 2007.
Lynn Bryant,
Department Clearance Officer, PRA, U.S.
Department of Justice.
[FR Doc. E7–11782 Filed 6–18–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0008]
Agency Information Collection
Activities: Proposed Collection;
Comments Requested
60-Day Notice of Information
Collection Under Review: Application
for Procurement Quota for Controlled
Substances and Ephedrine,
Pseudoephedrine, and
Phenylpropanolamine DEA Form 250.
rwilkins on PROD1PC63 with NOTICES
ACTION:
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA), will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. Comments
are encouraged and will be accepted
until August 20, 2007. This process is
VerDate Aug<31>2005
18:32 Jun 18, 2007
Jkt 211001
conducted in accordance with 5 CFR
1320.10.
If you have comments, especially on
the estimated public burden or
associated response time, suggestions,
or need a copy of the proposed
information collection instrument with
instructions or additional information,
please contact Mark W. Caverly, Chief,
Liaison and Policy Section, Office of
Diversion Control, Drug Enforcement
Administration, Washington, DC 20537.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agencies
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of this Information Collection
(1) Type of Information Collection:
Extension of an existing collection.
(2) Title of the Form/Collection:
Application for Procurement Quota for
Controlled Substances and Ephedrine,
Pseudoephedrine, and
Phenylpropanolamine.
(3) Agency form number, if any and
the applicable component of the
Department sponsoring the collection:
Form number: DEA Form 250.
Component: Office of Diversion
Control, Drug Enforcement
Administration, U.S. Department of
Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
Other: None.
Abstract: 21 U.S.C. 826 and 21 CFR
1303.12 and 1315.32 require that U.S.
companies who desire to use any basic
class of controlled substances listed in
Schedule I or II or the List I chemicals
ephedrine, pseudoephedrine, and
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
33775
phenylpropanolamine for purposes of
manufacturing during the next calendar
year shall apply on DEA Form 250 for
procurement quota for such class or List
I chemical.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: DEA estimates that each form
takes 1 hour to complete. DEA estimates
that 495 individual respondents will
respond to this form. DEA estimates that
1,346 responses are received annually.
(6) An estimate of the total public
burden (in hours) associated with the
collection: The total public burden for
this collection is 1,346 hours annually.
If additional information is required
contact: Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: June 12, 2007.
Lynn Bryant,
Department Clearance Officer, PRA, U.S.
Department of Justice.
[FR Doc. E7–11783 Filed 6–18–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0047]
Agency Information Collection
Activities
60–Day Notice of Information
Collection Under Review. Proposed
collection; comments requested:
Application for Import Quota for
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine DEA Form 488.
ACTION:
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA), will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. Comments
are encouraged and will be accepted
until August 20, 2007. This process is
conducted in accordance with 5 CFR
1320.10.
If you have comments, especially on
the estimated public burden or
associated response time, suggestions,
or need a copy of the proposed
information collection instrument with
instructions or additional information,
please contact Mark W. Caverly, Chief,
E:\FR\FM\19JNN1.SGM
19JNN1
Agencies
[Federal Register Volume 72, Number 117 (Tuesday, June 19, 2007)]
[Notices]
[Page 33775]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-11783]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117-0008]
Agency Information Collection Activities: Proposed Collection;
Comments Requested
ACTION: 60-Day Notice of Information Collection Under Review:
Application for Procurement Quota for Controlled Substances and
Ephedrine, Pseudoephedrine, and Phenylpropanolamine DEA Form 250.
-----------------------------------------------------------------------
The Department of Justice (DOJ), Drug Enforcement Administration
(DEA), will be submitting the following information collection request
to the Office of Management and Budget (OMB) for review and approval in
accordance with the Paperwork Reduction Act of 1995. The proposed
information collection is published to obtain comments from the public
and affected agencies. Comments are encouraged and will be accepted
until August 20, 2007. This process is conducted in accordance with 5
CFR 1320.10.
If you have comments, especially on the estimated public burden or
associated response time, suggestions, or need a copy of the proposed
information collection instrument with instructions or additional
information, please contact Mark W. Caverly, Chief, Liaison and Policy
Section, Office of Diversion Control, Drug Enforcement Administration,
Washington, DC 20537.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address one or more of the following
four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agencies estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be
collected; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Overview of this Information Collection
(1) Type of Information Collection: Extension of an existing
collection.
(2) Title of the Form/Collection: Application for Procurement Quota
for Controlled Substances and Ephedrine, Pseudoephedrine, and
Phenylpropanolamine.
(3) Agency form number, if any and the applicable component of the
Department sponsoring the collection:
Form number: DEA Form 250.
Component: Office of Diversion Control, Drug Enforcement
Administration, U.S. Department of Justice.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract:
Primary: Business or other for-profit.
Other: None.
Abstract: 21 U.S.C. 826 and 21 CFR 1303.12 and 1315.32 require that
U.S. companies who desire to use any basic class of controlled
substances listed in Schedule I or II or the List I chemicals
ephedrine, pseudoephedrine, and phenylpropanolamine for purposes of
manufacturing during the next calendar year shall apply on DEA Form 250
for procurement quota for such class or List I chemical.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond: DEA estimates
that each form takes 1 hour to complete. DEA estimates that 495
individual respondents will respond to this form. DEA estimates that
1,346 responses are received annually.
(6) An estimate of the total public burden (in hours) associated
with the collection: The total public burden for this collection is
1,346 hours annually.
If additional information is required contact: Lynn Bryant,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Patrick Henry
Building, Suite 1600, 601 D Street, NW., Washington, DC 20530.
Dated: June 12, 2007.
Lynn Bryant,
Department Clearance Officer, PRA, U.S. Department of Justice.
[FR Doc. E7-11783 Filed 6-18-07; 8:45 am]
BILLING CODE 4410-09-P